- Home
- ENSC vs INM Comparison
ENSC vs INM Comparison
Compare ENSC & INM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ENSC
- INM
- Stock Information
- Founded
- ENSC 2003
- INM 1981
- Country
- ENSC United States
- INM Canada
- Employees
- ENSC N/A
- INM N/A
- Industry
- ENSC Biotechnology: Pharmaceutical Preparations
- INM Biotechnology: Pharmaceutical Preparations
- Sector
- ENSC Health Care
- INM Health Care
- Exchange
- ENSC Nasdaq
- INM Nasdaq
- Market Cap
- ENSC 2.9M
- INM 3.2M
- IPO Year
- ENSC N/A
- INM N/A
- Fundamental
- Price
- ENSC $3.29
- INM $3.00
- Analyst Decision
- ENSC
- INM
- Analyst Count
- ENSC 0
- INM 0
- Target Price
- ENSC N/A
- INM N/A
- AVG Volume (30 Days)
- ENSC 4.9M
- INM 56.6K
- Earning Date
- ENSC 05-12-2025
- INM 05-13-2025
- Dividend Yield
- ENSC N/A
- INM N/A
- EPS Growth
- ENSC N/A
- INM N/A
- EPS
- ENSC N/A
- INM N/A
- Revenue
- ENSC $5,210,031.00
- INM $4,832,013.00
- Revenue This Year
- ENSC N/A
- INM N/A
- Revenue Next Year
- ENSC N/A
- INM N/A
- P/E Ratio
- ENSC N/A
- INM N/A
- Revenue Growth
- ENSC 133.58
- INM N/A
- 52 Week Low
- ENSC $1.62
- INM $1.72
- 52 Week High
- ENSC $14.67
- INM $15.70
- Technical
- Relative Strength Index (RSI)
- ENSC 55.92
- INM 62.76
- Support Level
- ENSC $3.02
- INM $2.56
- Resistance Level
- ENSC $4.85
- INM $3.05
- Average True Range (ATR)
- ENSC 0.40
- INM 0.27
- MACD
- ENSC 0.27
- INM 0.09
- Stochastic Oscillator
- ENSC 51.70
- INM 92.98
About ENSC Ensysce Biosciences Inc.
Ensysce Biosciences Inc is a clinical-stage biotech company using its proprietary technology platforms to develop safer prescription drugs. The company is developing a new class of powerful, tamper-proof opioids that prevent both drug abuse and overdoses. Its products are anticipated to provide safer options to treat severe pain and assist in preventing deaths caused by opioid abuse, reducing human and economic costs. The company's current development pipeline includes two new drug platforms: an abuse-resistant opioid prodrug technology, theTrypsin Activated Abuse Protection, or the TAAP platform, and an over-dose protection opioid prodrug technology, the Multi-Pill Abuse Resistant, or the MPAR platform. The Company currently operates in one business segment, which is pharmaceuticals.
About INM InMed Pharmaceuticals Inc.
InMed Pharmaceuticals Inc is a Canada based clinical-stage biopharmaceutical company. The company is engaged in the research and development of novel, cannabinoid-based, and manufacturing of Pharmaceutical grade cannabinoids. Its product portfolio includes INM-755, which is used for the treatment of epidermolysis bullosa; INM-088 for the treatment of glaucoma; INM-901 for Alzheimer's disease, INM-089's pharmacological and IntegraSyn which is a manufacturing system for Pharmaceutical-Grade Cannabinoids.